Anti-Secretory Drug in Treatment of Acute Watery Diarrhea
Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
In conclusion, racecadotril is an anti-secretory drug that exerts its antidiarrheal effect by
inhibiting intestinal enkephalinase. It is effective in reducing the volume and frequency of
stool output. racecadotril is well tolerated and safe by providing symptomatic relief and
reducing the severity of diarrhea as an adjuvant therapy during the acute attack of
gastroenteritis. It is recommended that the new generations of already discovered drugs for
control of secretory diarrhea should be studied to discover the ones with fewer side effects
to other systems in the body.